A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

NCT04857034 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosus, Discoid
Lupus Erythematosus, Subacute Cutaneous

Interventions

DRUG: Deucravacitinib
DRUG: Placebo

Sponsor

Bristol-Myers Squibb